2023-08-03 07:05:25
Scientists at UConn Health, affiliated with the University of Connecticut, in the United States, have made a crucial discovery that may play a key role in the treatment of Parkinson’s disease. The focus of the research is on the regulator of a gene known as LRRK2.
According to Fox News, in many cases of Parkinson’s, there is a genetic mutation of this gene, which performs different functions in the brain. This results in an overproduction of proteins encoded by this gene.
“Our study is the first to discover this mechanism. It is also important to identify a compound that can directly reduce LRRK2 levels, which means we could use it to treat patients with Parkinson’s,” said Yulan Xiong, professor of neuroscience at UConn Health.
“These findings make it possible to develop therapeutic compounds that use the body’s own regulatory mechanisms to control LRRK2, which may minimize potential adverse side effects,” James Beck of the Parkinson’s Foundation told Fox News. This research paves the way for new perspectives in the treatment of this neurological disease and offers hope for those who suffer from Parkinson’s.
Also Read: 5 Tips on How to Face Difficult Conversations in Marriage
#study #key #treating #Parkinsons #disease